Additionally, the applicant stated that VANFLYTA, if approved, would be the only AML drug indicated for continuation monotherapy following consolidation chemotherapy (for up to 3 years), based on showing activity as a single agent for that use, and that therefore, the technology meets the newness criterion
doi: 10.1007/s10753-023-01954-8 171 KarSShahshahanHMishraPK
For Canadians dealing with post-weight-loss skin laxity, injectable GHK-Cu offers a non-surgical option backed by over 40 years of scientific research and a strong safety profile
astrocytes in the grey matter lose ~ 50% of their perivascular endfeet
Researchers believe that "linear lesions" on the tongue are an early clinical sign of a vitamin B12 deficiency
A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) is treated as a contraindication for the class